{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:15:44Z","timestamp":1789020944073,"version":"build-2803163510"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare, Japan","doi-asserted-by":"publisher","award":["21AA2007"],"award-info":[{"award-number":["21AA2007"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["20H03907"],"award-info":[{"award-number":["20H03907"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["21H03159"],"award-info":[{"award-number":["21H03159"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["21K08123"],"award-info":[{"award-number":["21K08123"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medtronic Japan, Biotronik Japan, Simplex Quantum, Boston Scientific Japan and Fukuda Denshi"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure (HF) is increasing in prevalence worldwide. We explored whether adults with trace and positive proteinuria were at a high risk for incident HF compared with those with negative proteinuria using a nationwide epidemiological database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is an observational cohort study using the JMDC Claims Database collected between 2005 and 2020. This is a population-based sample [n = 1 021 943; median age 44 years (interquartile range 37\u201352); 54.8% men]. No participants had a known history of cardiovascular disease (CVD). Each participant was categorized into three groups according to the urine dipstick test results: negative proteinuria (n = 902 273), trace proteinuria (n = 89 599) and positive proteinuria (\u22651+; n = 30 071). The primary outcome was HF. The secondary outcomes were myocardial infarction (MI), stroke and atrial fibrillation (AF). We performed multivariable Cox regression analyses to identify the association between the proteinuria category and incident HF and other CVD events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a mean follow-up of 1150 \u00b1 920 days, 17 182 incident HF events occurred. After multivariable adjustment, hazard ratios for HF events were 1.09 [95% confidence interval (CI) 1.03\u20131.15] and 1.59 (95% CI 1.49\u20131.70) for trace proteinuria and positive proteinuria versus negative proteinuria, respectively. This association was present irrespective of clinical characteristics. A stepwise increase in the risk of MI, stroke and AF with proteinuria category was also observed. Our primary results were confirmed in participants after multiple imputations for missing values and in those having no medications for hypertension, diabetes mellitus and dyslipidemia. The discriminative predictive value for HF events improved by adding the results of urine dipstick tests to traditional risk factors [net reclassification improvement 0.0497 (95% CI 0.0346\u20130.0648); P &amp;lt; 0.001].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Not only positive proteinuria, but also trace proteinuria was associated with a greater incidence of HF in the general population. Semiquantitative assessment of proteinuria would be informative for the risk stratification of HF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfab248","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T10:47:47Z","timestamp":1631011667000},"page":"1691-1699","source":"Crossref","is-referenced-by-count":16,"title":["Semiquantitative assessed proteinuria and risk of heart failure: analysis of a nationwide epidemiological database"],"prefix":"10.1093","volume":"37","author":[{"given":"Akira","family":"Fukui","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine , Tokyo, Japan"},{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2553-6170","authenticated-orcid":false,"given":"Hidehiro","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"},{"name":"Department of Advanced Cardiology, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yano","sequence":"additional","affiliation":[{"name":"YCU Center for Novel and Exploratory Clinical Trials, Yokohama City University Hospital , Yokohama, Japan"},{"name":"Department of Family Medicine and Community Health, Duke University , Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"},{"name":"Department of Cardiology, New Tokyo Hospital , Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, Faculty of Medicine, University of Tsukuba , Ibaraki, Japan"},{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kiriyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kamon","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Fujiu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"},{"name":"Department of Advanced Cardiology, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Michihata","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, New Tokyo Hospital , Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Kagawa University , Kagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2534-0939","authenticated-orcid":false,"given":"Koichi","family":"Node","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University , Saga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"2022082302374281200_gfab248-B1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"2022082302374281200_gfab248-B2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"2022082302374281200_gfab248-B3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0272-6386(99)70442-7","article-title":"Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation","volume":"33","author":"Keane","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2022082302374281200_gfab248-B4","first-page":"S1","article-title":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2022082302374281200_gfab248-B5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"2022082302374281200_gfab248-B6","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"2022082302374281200_gfab248-B7","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","article-title":"Proteinuria and the risk of developing end-stage renal disease","volume":"63","author":"Iseki","year":"2003","journal-title":"Kidney Int"},{"key":"2022082302374281200_gfab248-B8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.111.064097","article-title":"Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation","volume":"125","author":"Rafiq","year":"2012","journal-title":"Circulation"},{"key":"2022082302374281200_gfab248-B9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"2022082302374281200_gfab248-B10","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1523-1755.2000.00331.x","article-title":"Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study","volume":"58","author":"Festa","year":"2000","journal-title":"Kidney Int"},{"key":"2022082302374281200_gfab248-B11","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2337\/dc18-0718","article-title":"Association of albuminuria with intraglomerular hydrostatic pressure and insulin resistance in subjects with impaired fasting glucose and\/or impaired glucose tolerance","volume":"41","author":"Tsuda","year":"2018","journal-title":"Diabetes Care"},{"key":"2022082302374281200_gfab248-B12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0895-7061(03)01009-4","article-title":"Association between microalbuminuria and the metabolic syndrome: NHANES III","volume":"16","author":"Palaniappan","year":"2003","journal-title":"Am J Hypertens"},{"key":"2022082302374281200_gfab248-B13","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","article-title":"Metabolic syndrome and kidney disease: a systematic review and meta-analysis","volume":"6","author":"Thomas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022082302374281200_gfab248-B14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"2022082302374281200_gfab248-B15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.STR.28.1.45","article-title":"A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study","volume":"28","author":"Nakayama","year":"1997","journal-title":"Stroke"},{"key":"2022082302374281200_gfab248-B16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2796.2003.01264.x","article-title":"Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study","volume":"255","author":"Yuyun","year":"2004","journal-title":"J Intern Med"},{"key":"2022082302374281200_gfab248-B17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archinte.166.8.884","article-title":"Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up: the Honolulu Heart Program","volume":"166","author":"Madison","year":"2006","journal-title":"Arch Intern Med"},{"key":"2022082302374281200_gfab248-B18","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"2022082302374281200_gfab248-B19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","article-title":"Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study","volume":"112","author":"\u00c4rnl\u00f6v","year":"2005","journal-title":"Circulation"},{"key":"2022082302374281200_gfab248-B20","doi-asserted-by":"crossref","first-page":"e005685","DOI":"10.1161\/JAHA.117.005685","article-title":"Association of proteinuria and incident atrial fibrillation in patients with intact and reduced kidney function","volume":"6","author":"Molnar","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022082302374281200_gfab248-B21","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1038\/s41598-017-06579-0","article-title":"Proteinuria detected by urine dipstick test as a risk factor for atrial fibrillation: a nationwide population-based study","volume":"7","author":"Lim","year":"2017","journal-title":"Sci Rep"},{"key":"2022082302374281200_gfab248-B22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1161\/CIRCULATIONAHA.120.047873","article-title":"Risk of cardiovascular events after spouse\u2019s ICU admission","volume":"142","author":"Ohbe","year":"2020","journal-title":"Circulation"},{"key":"2022082302374281200_gfab248-B23","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2020.09.545","article-title":"Association of cardiovascular health metrics with subsequent cardiovascular disease in young adults","volume":"76","author":"Kaneko","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022082302374281200_gfab248-B24","doi-asserted-by":"crossref","first-page":"e017963","DOI":"10.1161\/JAHA.120.017963","article-title":"Association of isolated diastolic hypertension based on the cutoff value in the 2017 American College of Cardiology\/American Heart Association blood pressure guidelines with subsequent cardiovascular events in the general population","volume":"9","author":"Kaneko","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022082302374281200_gfab248-B25","doi-asserted-by":"crossref","first-page":"19674","DOI":"10.1038\/s41598-020-76669-z","article-title":"Restfulness from sleep and subsequent cardiovascular disease in the general population","volume":"10","author":"Kaneko","year":"2020","journal-title":"Sci Rep"},{"key":"2022082302374281200_gfab248-B26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/105294199277860","article-title":"The international conference on harmonization good clinical practice guideline","volume":"6","author":"Dixon","year":"1998","journal-title":"Qual Assur"},{"key":"2022082302374281200_gfab248-B27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5551\/jat.12.301","article-title":"Metabolic syndrome\u2014definition and diagnostic criteria in Japan","volume":"12","author":"Matsuzawa","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"2022082302374281200_gfab248-B28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2022082302374281200_gfab248-B29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjcard.2020.11.038","article-title":"Lipid profile and subsequent cardiovascular disease among young adults aged &lt;50 years","volume":"142","author":"Kaneko","year":"2021","journal-title":"Am J Cardiol"},{"key":"2022082302374281200_gfab248-B30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2020.05.015","article-title":"Association of body weight gain with subsequent cardiovascular event in non-obese general population without overt cardiovascular disease","volume":"308","author":"Kaneko","year":"2020","journal-title":"Atherosclerosis"},{"key":"2022082302374281200_gfab248-B31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/STROKEAHA.116.015147","article-title":"Impact of rehabilitation on outcomes in patients with ischemic stroke: a nationwide retrospective cohort study in Japan","volume":"48","author":"Yagi","year":"2017","journal-title":"Stroke"},{"key":"2022082302374281200_gfab248-B32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7326\/M13-1522","article-title":"Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide","volume":"160","author":"Leening","year":"2014","journal-title":"Ann Intern Med"},{"key":"2022082302374281200_gfab248-B33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00380-020-01596-y","article-title":"Role of dipstick proteinuria for predicting cardiovascular events: a Japanese cardiovascular hospital database analysis","volume":"35","author":"Arai","year":"2020","journal-title":"Heart Vessels"},{"key":"2022082302374281200_gfab248-B34","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2007.12.048","article-title":"Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study","volume":"51","author":"Bahrami","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022082302374281200_gfab248-B35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"2022082302374281200_gfab248-B36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"2022082302374281200_gfab248-B37","doi-asserted-by":"crossref","first-page":"e000810","DOI":"10.1161\/JAHA.114.000810","article-title":"The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation","volume":"3","author":"Menne","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2022082302374281200_gfab248-B38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.118.034222","article-title":"Canagliflozin and heart failure in type 2 diabetes mellitus: results from the CANVAS program","volume":"138","author":"Radholm","year":"2018","journal-title":"Circulation"},{"key":"2022082302374281200_gfab248-B39","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.119.042685","article-title":"Heart failure risk stratification and efficacy of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus","volume":"140","author":"Berg","year":"2019","journal-title":"Circulation"},{"key":"2022082302374281200_gfab248-B40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2022082302374281200_gfab248-B41","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2022082302374281200_gfab248-B42","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"Kidney Disease: Improving Global Outcomes Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"key":"2022082302374281200_gfab248-B43","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"2022082302374281200_gfab248-B44","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"Kidney Disease: Improving Global Outcomes Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","year":"2020","journal-title":"Kidney Int"},{"key":"2022082302374281200_gfab248-B45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on \u2018KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u2019","volume":"84","author":"Andrassy","year":"2013","journal-title":"Kidney Int"},{"key":"2022082302374281200_gfab248-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-018-1648-1","article-title":"Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018","volume":"23","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2022082302374281200_gfab248-B47","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/M20-0529","article-title":"Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant-based meta-analysis","volume":"173","author":"Sumida","year":"2020","journal-title":"Ann Intern Med"},{"key":"2022082302374281200_gfab248-B48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijcard.2016.07.222","article-title":"Association between mortality and incidence rates of coronary heart disease and stroke: the Japan Public Health Center-based prospective (JPHC) study","volume":"222","author":"Saito","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022082302374281200_gfab248-B49","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1253\/circj.CJ-17-0277","article-title":"Development of a basic risk score for incident atrial fibrillation in a Japanese general population \u2013 the Suita study","volume":"81","author":"Kokubo","year":"2017","journal-title":"Circ J"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfab248\/40521005\/gfab248.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/9\/1691\/45497419\/gfab248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/9\/1691\/45497419\/gfab248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T22:39:57Z","timestamp":1661207997000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/37\/9\/1691\/6365949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,7]]},"published-print":{"date-parts":[[2022,8,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfab248","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9]]},"published":{"date-parts":[[2021,9,7]]}}}